Overview

HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC

Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This study is being done to understand if using birth control causes changes in the immune cells within the reproductive tract of healthy women. Immune cells are important because they help prevent infections from starting and help fight infections that have started. Immune cells are also the type of cells that HIV (human immunodeficiency virus) infects so understanding more about them will help to better understand how to prevent the spread of HIV. Immune cells will be studied from the reproductive tract of women who want to start using one of the following contraceptives: Depo-Provera (DMPA), NET-EN, MPA/E2 (Cyclofem®), the levonorgestrel subdermal implant (Jadelle® ), the etonogestrel subdermal implant (Implanon® or Nexplanon® ) and the copper IUD.
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
University of Zimbabwe
Treatments:
Contraceptive Agents
Copper
Desogestrel
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Etonogestrel
Levonorgestrel
Medroxyprogesterone
Medroxyprogesterone Acetate
Norethindrone
Norethindrone acetate
Norethindrone enanthate
Polyestradiol phosphate